Literature DB >> 26503281

Pooled Amplicon Deep Sequencing of Candidate Plasmodium falciparum Transmission-Blocking Vaccine Antigens.

Jonathan J Juliano1, Christian M Parobek2, Nicholas F Brazeau2, Billy Ngasala2, Milijaona Randrianarivelojosia2, Chanthap Lon2, Kashamuka Mwandagalirwa2, Antoinette Tshefu2, Ravi Dhar2, Bidyut K Das2, Irving Hoffman2, Francis Martinson2, Andreas Mårtensson2, David L Saunders2, Nirbhay Kumar2, Steven R Meshnick2.   

Abstract

Polymorphisms within Plasmodium falciparum vaccine candidate antigens have the potential to compromise vaccine efficacy. Understanding the allele frequencies of polymorphisms in critical binding regions of antigens can help in the designing of strain-transcendent vaccines. Here, we adopt a pooled deep-sequencing approach, originally designed to study P. falciparum drug resistance mutations, to study the diversity of two leading transmission-blocking vaccine candidates, Pfs25 and Pfs48/45. We sequenced 329 P. falciparum field isolates from six different geographic regions. Pfs25 showed little diversity, with only one known polymorphism identified in the region associated with binding of transmission-blocking antibodies among our isolates. However, we identified four new mutations among eight non-synonymous mutations within the presumed antibody-binding region of Pfs48/45. Pooled deep sequencing provides a scalable and cost-effective approach for the targeted study of allele frequencies of P. falciparum candidate vaccine antigens. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26503281      PMCID: PMC4710419          DOI: 10.4269/ajtmh.15-0571

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria.

Authors:  Bita Bordbar; Nicaise Tuikue Ndam; Emmanuelle Renard; Sayeh Jafari-Guemouri; Livingstone Tavul; Charlie Jennison; Sédami Gnidehou; Rachida Tahar; Dionicia Gamboa; Jorge Bendezu; Didier Menard; Alyssa E Barry; Philippe Deloron; Audrey Sabbagh
Journal:  Infect Genet Evol       Date:  2014-04-21       Impact factor: 3.342

2.  Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse.

Authors:  Jessica T Lin; Nicholas J Hathaway; David L Saunders; Chanthap Lon; Sujata Balasubramanian; Oksana Kharabora; Panita Gosi; Sabaithip Sriwichai; Laurel Kartchner; Char Meng Chuor; Prom Satharath; Charlotte Lanteri; Jeffrey A Bailey; Jonathan J Juliano
Journal:  J Infect Dis       Date:  2015-03-06       Impact factor: 5.226

3.  Transmission blocking malaria vaccines.

Authors:  R Carter
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

4.  Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes.

Authors:  Steve M Taylor; Christian M Parobek; Nash Aragam; Billy E Ngasala; Andreas Mårtensson; Steven R Meshnick; Jonathan J Juliano
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

5.  Structure and mechanism of a transmission blocking vaccine candidate protein Pfs25 from P. falciparum: a molecular modeling and docking study.

Authors:  Babita Sharma
Journal:  In Silico Biol       Date:  2008

6.  Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies.

Authors:  Nikolay Outchkourov; Adriaan Vermunt; Josephine Jansen; Anita Kaan; Will Roeffen; Karina Teelen; Edwin Lasonder; Anneke Braks; Marga van de Vegte-Bolmer; Li Yan Qiu; Robert Sauerwein; Hendrik G Stunnenberg
Journal:  J Biol Chem       Date:  2007-04-09       Impact factor: 5.157

7.  Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development.

Authors:  Shannon L Takala; Drissa Coulibaly; Mahamadou A Thera; Adrian H Batchelor; Michael P Cummings; Ananias A Escalante; Amed Ouattara; Karim Traoré; Amadou Niangaly; Abdoulaye A Djimdé; Ogobara K Doumbo; Christopher V Plowe
Journal:  Sci Transl Med       Date:  2009-10-14       Impact factor: 17.956

8.  Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study.

Authors:  Steve M Taylor; Christian M Parobek; Derrick K DeConti; Kassoum Kayentao; Sheick Oumar Coulibaly; Brian M Greenwood; Harry Tagbor; John Williams; Kalifa Bojang; Fanta Njie; Meghna Desai; Simon Kariuki; Julie Gutman; Don P Mathanga; Andreas Mårtensson; Billy Ngasala; Melissa D Conrad; Philip J Rosenthal; Antoinette K Tshefu; Ann M Moormann; John M Vulule; Ogobara K Doumbo; Feiko O Ter Kuile; Steven R Meshnick; Jeffrey A Bailey; Jonathan J Juliano
Journal:  J Infect Dis       Date:  2014-09-01       Impact factor: 5.226

9.  Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.

Authors:  Meera Venkatesan; Nahla B Gadalla; Kasia Stepniewska; Prabin Dahal; Christian Nsanzabana; Clarissa Moriera; Ric N Price; Andreas Mårtensson; Philip J Rosenthal; Grant Dorsey; Colin J Sutherland; Philippe Guérin; Timothy M E Davis; Didier Ménard; Ishag Adam; George Ademowo; Cesar Arze; Frederick N Baliraine; Nicole Berens-Riha; Anders Björkman; Steffen Borrmann; Francesco Checchi; Meghna Desai; Mehul Dhorda; Abdoulaye A Djimdé; Badria B El-Sayed; Teferi Eshetu; Frederick Eyase; Catherine Falade; Jean-François Faucher; Gabrielle Fröberg; Anastasia Grivoyannis; Sally Hamour; Sandrine Houzé; Jacob Johnson; Erasmus Kamugisha; Simon Kariuki; Jean-René Kiechel; Fred Kironde; Poul-Erik Kofoed; Jacques LeBras; Maja Malmberg; Leah Mwai; Billy Ngasala; Francois Nosten; Samuel L Nsobya; Alexis Nzila; Mary Oguike; Sabina Dahlström Otienoburu; Bernhards Ogutu; Jean-Bosco Ouédraogo; Patrice Piola; Lars Rombo; Birgit Schramm; A Fabrice Somé; Julie Thwing; Johan Ursing; Rina P M Wong; Ahmed Zeynudin; Issaka Zongo; Christopher V Plowe; Carol Hopkins Sibley
Journal:  Am J Trop Med Hyg       Date:  2014-07-21       Impact factor: 2.345

10.  Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.

Authors:  Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Dapa A Diallo; Abdoulaye K Kone; Ando B Guindo; Karim Traore; Alassane Dicko; Issaka Sagara; Mahamadou S Sissoko; Mounirou Baby; Mady Sissoko; Issa Diarra; Amadou Niangaly; Amagana Dolo; Modibo Daou; Sory I Diawara; D Gray Heppner; V Ann Stewart; Evelina Angov; Elke S Bergmann-Leitner; David E Lanar; Sheetij Dutta; Lorraine Soisson; Carter L Diggs; Amanda Leach; Alex Owusu; Marie-Claude Dubois; Joe Cohen; Jason N Nixon; Aric Gregson; Shannon L Takala; Kirsten E Lyke; Christopher V Plowe
Journal:  PLoS One       Date:  2008-01-23       Impact factor: 3.240

View more
  9 in total

Review 1.  Transmission-Blocking Vaccines: Old Friends and New Prospects.

Authors:  Festus K Acquah; Joshua Adjah; Kim C Williamson; Linda E Amoah
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.

Authors:  Noah H Paul; Arthur Vengesai; Takafira Mduluza; James Chipeta; Nicholas Midzi; Geetha P Bansal; Nirbhay Kumar
Journal:  Acta Trop       Date:  2016-08-01       Impact factor: 3.112

Review 3.  Applying next-generation sequencing to track falciparum malaria in sub-Saharan Africa.

Authors:  Sofonias K Tessema; Jaishree Raman; Craig W Duffy; Deus S Ishengoma; Alfred Amambua-Ngwa; Bryan Greenhouse
Journal:  Malar J       Date:  2019-09-03       Impact factor: 2.979

4.  Signatures of selection and drivers for novel mutation on transmission-blocking vaccine candidate Pfs25 gene in western Kenya.

Authors:  Kevin O Ochwedo; Shirley A Onyango; Collince J Omondi; Pauline W Orondo; Benyl M Ondeto; Ming-Chieh Lee; Harrysone E Atieli; Sidney O Ogolla; Andrew K Githeko; Antony C A Otieno; Wolfgang R Mukabana; Guiyun Yan; Daibin Zhong; James W Kazura
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

5.  Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers.

Authors:  Chanon Kunasol; Arjen M Dondorp; Elizabeth M Batty; Vorthunju Nakhonsri; Puritat Sinjanakhom; Nicholas P J Day; Mallika Imwong
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

6.  A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity.

Authors:  Robin H Miller; Nicholas J Hathaway; Oksana Kharabora; Kashamuka Mwandagalirwa; Antoinette Tshefu; Steven R Meshnick; Steve M Taylor; Jonathan J Juliano; V Ann Stewart; Jeffrey A Bailey
Journal:  Malar J       Date:  2017-12-16       Impact factor: 2.979

7.  Multiplicity and molecular epidemiology of Plasmodium vivax and Plasmodium falciparum infections in East Africa.

Authors:  Daibin Zhong; Eugenia Lo; Xiaoming Wang; Delenasaw Yewhalaw; Guofa Zhou; Harrysone E Atieli; Andrew Githeko; Elizabeth Hemming-Schroeder; Ming-Chieh Lee; Yaw Afrane; Guiyun Yan
Journal:  Malar J       Date:  2018-05-02       Impact factor: 2.979

Review 8.  Diversify and Conquer: The Vaccine Escapism of Plasmodium falciparum.

Authors:  Alena Pance
Journal:  Microorganisms       Date:  2020-11-07

9.  Targeted Next Generation Sequencing for malaria research in Africa: current status and outlook.

Authors:  Anita Ghansah; Edwin Kamau; Alfred Amambua-Ngwa; Deus S Ishengoma; Oumou Maiga-Ascofare; Lucas Amenga-Etego; Awa Deme; William Yavo; Milijaona Randrianarivelojosia; Lynette Isabella Ochola-Oyier; Gideon Kofi Helegbe; Jeffery Bailey; Michael Alifrangis; Abdoulaye Djimde
Journal:  Malar J       Date:  2019-09-23       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.